| |
|
|
|
Xtalks, Online
2024-12-12
How can anti-nuclear antibody (ANA) positive patients who also have undifferentiated connective tissue disease (UCTD) quickly find a diagnosis? Conventional biomarker tests available today can still leave some patients without the required answers to end their diagnostic journey.
In this webinar, attendees will gain insights into emergent biomarkers for systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The speakers will share how novel T Cell biomarkers can offer more confident diagnoses of SLE, particularly when conventional biomarkers are insufficient. Moreover, the attendees will be introduced to a new panel of biomarkers specifically designed to address the diagnostic challenges of seronegative RA, enhancing detection and treatment strategies.
The expert speakers will also share their research into novel biomarkers that can become tools for attendees and help in the confident diagnosis of this challenging patient population.
Register for this webinar today to learn how clinical biomarkers can help expedite diagnoses and optimize treatment strategies for ANA patients with undifferentiated connective tissue disease.
Keywords: Lupus, Diagnostic Test, Clinical Research, Arthritis, Biomarkers, Rheumatoid Arthritis, Biomarker Discovery, Diagnostics, Therapeutic Areas, Rare Diseases/Orphan Drugs
|
|
|
|
|
|
|
|
Organized by:
|
|
Xtalks |
|
|
Invited Speakers:
|
|
Dr. George Muñoz, MD, Rheumatologist and Internist, The Institute for Functional Medicine
Dr. Andrew Concoff, MD, Rheumatologist and Chief Innovation Officer, Exagen Inc.
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2024-12-12
|
|
|
|
|
|
|
|
Registration:
|
|
Free Registration
|
|
|
E-mail:
|
|
tristan@xtalks.com
|
|
|
|
|
|
|
|
|
|
|
|
|